Prenetics Global Limited

3.71
0.11 (3.06%)
At close: Apr 14, 2025, 3:49 PM
3.54
-4.51%
After-hours: Apr 14, 2025, 06:00 PM EDT
3.06%
Bid 3.47
Market Cap 45.33M
Revenue (ttm) 25.56M
Net Income (ttm) -49.01M
EPS (ttm) -3.73
PE Ratio (ttm) -0.99
Forward PE -9.46
Analyst Buy
Ask 3.85
Volume 10,252
Avg. Volume (20D) 11,632
Open 3.84
Previous Close 3.60
Day's Range 3.55 - 3.84
52-Week Range 2.85 - 7.84
Beta -0.21

About PRE

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer ...

Sector Healthcare
IPO Date Jul 16, 2021
Employees 320
Stock Exchange NASDAQ
Ticker Symbol PRE
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for PRE stock is "Buy." The 12-month stock price forecast is $9, which is an increase of 142.59% from the latest price.

Stock Forecasts
6 months ago
+19.13%
Prenetics Global shares are trading higher followi... Unlock content with Pro Subscription
7 months ago
+5.47%
Prenetics Global Limited shares are trading higher after the company announced the acquisition of Europa Sports Partners and its subsidiary, Hubmatrix.